Two Sigma Investments
TEVA icon

Two Sigma Investments’s Teva Pharmaceuticals TEVA Stock Holding History

Two Sigma Investments’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-15,200
Closed -$474K – 4920
2025
Q4 		$474K Buy
+15,200
New +$374K ﹤0.01% 3335
2021
Q4 		– Sell
-90,000
Closed -$877K – 4881
2021
Q3 		$877K Sell
90,000
-10,400
-10% -$97.4K ﹤0.01% 2726
2021
Q2 		$994K Buy
100,400
+16,700
+20% +$177K ﹤0.01% 2481
2021
Q1 		$966K Buy
+83,700
New +$960K ﹤0.01% 2359
2020
Q4 		– Sell
-49,200
Closed -$443K – 3755
2020
Q3 		$443K Sell
49,200
-13,100
-21% -$139K ﹤0.01% 2335
2020
Q2 		$768K Sell
62,300
-124,400
-67% -$1.41M ﹤0.01% 1708
2020
Q1 		$1.68M Sell
186,700
-304,900
-62% -$3.12M 0.01% 1066
2019
Q4 		$4.82M Buy
491,600
+445,000
+955% +$3.97M 0.01% 980
2019
Q3 		$321K Sell
46,600
-86,700
-65% -$664K ﹤0.01% 2920
2019
Q2 		$1.23M Buy
133,300
+112,400
+538% +$1.36M ﹤0.01% 1772
2019
Q1 		$328K Buy
+20,900
New +$369K ﹤0.01% 2541
2018
Q4 		– Sell
-51,400
Closed -$1.11M – 3514
2018
Q3 		$1.11M Sell
51,400
-3,400
-6% -$78.9K ﹤0.01% 1903
2018
Q2 		$1.33M Sell
54,800
-156,300
-74% -$3.19M ﹤0.01% 1924
2018
Q1 		$3.61M Buy
211,100
+200,700
+1,930% +$3.92M 0.01% 1137
2017
Q4 		$197K Buy
+10,400
New +$156K ﹤0.01% 2935
2017
Q3 		– Sell
-29,000
Closed -$963K – 3181
2017
Q2 		$963K Sell
29,000
-138,300
-83% -$4.28M ﹤0.01% 1918
2017
Q1 		$5.37M Buy
167,300
+156,300
+1,421% +$5.33M 0.02% 911
2016
Q4 		$399K Sell
11,000
-167,700
-94% -$6.7M ﹤0.01% 2628
2016
Q3 		$8.22M Buy
178,700
+168,700
+1,687% +$8.8M 0.03% 639
2016
Q2 		$502K Buy
+10,000
New +$532K ﹤0.01% 2253
2016
Q1 		– Sell
-7,000
Closed -$459K – 3119
2015
Q4 		$459K Sell
7,000
-10,000
-59% -$618K ﹤0.01% 2012
2015
Q3 		$960K Buy
+17,000
New +$1.1M ﹤0.01% 1225

Other funds holding TEVA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $14.7B AUM 47% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $5.06B AUM 91.14% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Two Sigma Investments's TEVA Position: Q1 2026 in Review

Two Sigma Investments increased its Teva Pharmaceuticals (TEVA) stake by 61% in Q1 2026, buying an estimated $4.47M and bringing the position to 366,791 shares worth $11M. The position accounts for 0.01% of the portfolio, ranked #1342.

Two Sigma Investments first reported a position in TEVA in Q2 2013 and has held it in 48 quarters since. The position peaked at $142M in Q4 2016. 651 funds tracked by Wall St. Rank hold TEVA as of Q1 2026.

  • Two Sigma Investments held 366,791 shares of Teva Pharmaceuticals worth $11M as of Q1 2026.
  • Two Sigma Investments bought 138,970 Teva Pharmaceuticals shares in Q1 2026, an estimated $4.47M.
  • Teva Pharmaceuticals made up 0.01% of Two Sigma Investments's portfolio in Q1 2026, its #1342 holding.
  • Two Sigma Investments first reported a position in Teva Pharmaceuticals in Q2 2013 and has held it in 48 quarters since.
  • Two Sigma Investments's Teva Pharmaceuticals position peaked at $142M in Q4 2016.
  • 651 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q1 2026.

Based on Two Sigma Investments's 13F filing for Q1 2026, filed 15 May 2026.